Cargando…

Novel exosome-related risk signature as prognostic biomarkers in glioblastoma

Exosomes are progressively being detected as an indicator for the diagnosis and prognosis of cancer in clinical settings. Many clinical trials have confirmed the impact of exosomes on tumor growth, particularly in anti-tumor immunity and immunosuppression of exosomes. Therefore, we developed a risk...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ding, Mingyan, Xu, Qiang, Jin, Xiuying, Han, Zhezhu, Jiang, Hao, Sun, Honghua, Jin, Yongmin, Piao, Zhengri, Zhang, Songnan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9971586/ https://www.ncbi.nlm.nih.gov/pubmed/36865549 http://dx.doi.org/10.3389/fimmu.2023.1071023

Ejemplares similares

Immune Cell Infiltration and Relevant Gene Signatures in the Tumor Microenvironment that Significantly Associates With the Prognosis of Patients With Breast Cancer
por: Xu, Qiang, et al.
Publicado: (2022)

Comparative Study of Application of Computed Tomography/Ultrasound and Computed Tomography Imaging Guidance Methods in the Microwave Ablation of Liver Cancer
por: Liang, Junhua, et al.
Publicado: (2023)

Identification of Immune-Related lncRNA Prognostic Signature and Molecular Subtypes for Glioblastoma
por: Yu, Wanli, et al.
Publicado: (2021)

Potentiality of Exosomal Proteins as Novel Cancer Biomarkers for Liquid Biopsy
por: Hu, Chunmiao, et al.
Publicado: (2022)

Identification of a necroptosis-related gene signature as a novel prognostic biomarker of cholangiocarcinoma
por: Xu, Lixia, et al.
Publicado: (2023)

Tear-derived exosomal biomarkers of Graves’ ophthalmopathy
por: Shi, Ting-Ting, et al.
Publicado: (2022)

Metabolic-related gene pairs signature analysis identifies ABCA1 expression levels on tumor-associated macrophages as a prognostic biomarker in primary IDH(WT) glioblastoma
por: Wang, Shiqun, et al.
Publicado: (2022)

Mining of immunological and prognostic-related biomarker for cervical cancer based on immune cell signatures
por: Wang, Nana, et al.
Publicado: (2022)

Identification and validation of neurotrophic factor-related gene signatures in glioblastoma and Parkinson’s disease
por: Zhao, Songyun, et al.
Publicado: (2023)

Combining single-cell sequencing and spatial transcriptome sequencing to identify exosome-related features of glioblastoma and constructing a prognostic model to identify BARD1 as a potential therapeutic target for GBM patients
por: Zhao, Songyun, et al.
Publicado: (2023)

Identification and validation of SNHG gene signature to predict malignant behaviors and therapeutic responses in glioblastoma
por: Fan, Yang, et al.
Publicado: (2022)

Editorial: Genomics, proteomics and immunological signatures as diagnostic, predictive, and prognostic biomarkers in head and neck cancers
por: Raza, Afsheen, et al.
Publicado: (2023)

The combined signatures of telomere and immune cell landscape provide a prognostic and therapeutic biomarker in glioma
por: Han, Xu, et al.
Publicado: (2023)

A novel prognostic related lncRNA signature associated with amino acid metabolism in glioma
por: Lei, Qiang, et al.
Publicado: (2023)

A Novel Signature of 23 Immunity-Related Gene Pairs Is Prognostic of Cutaneous Melanoma
por: Xue, Ya-Nan, et al.
Publicado: (2020)

Deciphering the Prognostic Implications of the Components and Signatures in the Immune Microenvironment of Pancreatic Ductal Adenocarcinoma
por: Tang, Rong, et al.
Publicado: (2021)

A novel prognostic signatures based on metastasis- and immune-related gene pairs for colorectal cancer
por: Pan, Bei, et al.
Publicado: (2023)

Prognostic signatures of sphingolipids: Understanding the immune landscape and predictive role in immunotherapy response and outcomes of hepatocellular carcinoma
por: Zhang, Xin, et al.
Publicado: (2023)

Immunosuppressive Protein Signatures Carried by Syncytiotrophoblast-Derived Exosomes and Their Role in Human Pregnancy
por: Mincheva-Nilsson, Lucia
Publicado: (2021)

Identifying a baicalein-related prognostic signature contributes to prognosis prediction and tumor microenvironment of pancreatic cancer
por: Zhang, Citing, et al.
Publicado: (2023)

Development of a novel glycolysis-related genes signature for isocitrate dehydrogenase 1-associated glioblastoma multiforme
por: Cai, Xiaomin, et al.
Publicado: (2022)

From the Immune Profile to the Immunoscore: Signatures for Improving Postsurgical Prognostic Prediction of Pancreatic Neuroendocrine Tumors
por: Wei, Miaoyan, et al.
Publicado: (2021)

Exosomes Derived From Septic Mouse Serum Modulate Immune Responses via Exosome-Associated Cytokines
por: Gao, Kun, et al.
Publicado: (2019)

Targeting and Therapy of Glioblastoma in a Mouse Model Using Exosomes Derived From Natural Killer Cells
por: Zhu, Liya, et al.
Publicado: (2018)

A Novel Ferroptosis-Related Long Non-Coding RNA Prognostic Signature Correlates With Genomic Heterogeneity, Immunosuppressive Phenotype, and Drug Sensitivity in Hepatocellular Carcinoma
por: Li, Guanghao, et al.
Publicado: (2022)

Identification and validation of an anoikis-associated gene signature to predict clinical character, stemness, IDH mutation, and immune filtration in glioblastoma
por: Sun, Zhongzheng, et al.
Publicado: (2022)

Exosomal circRNAs as promising liquid biopsy biomarkers for glioma
por: Wu, Xiaoke, et al.
Publicado: (2023)

Cargoes of exosomes function as potential biomarkers for Mycobacterium tuberculosis infection
por: Wang, Nan, et al.
Publicado: (2023)

Prognostic and immunological significance of an M1 macrophage-related gene signature in osteosarcoma
por: Mao, Xiaoyu, et al.
Publicado: (2023)

Glioblastoma-Derived Exosomes as Nanopharmaceutics for Improved Glioma Treatment
por: Lee, Hyeji, et al.
Publicado: (2022)

LAYN Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric and Colon Cancers
por: Pan, Jing-hua, et al.
Publicado: (2019)

Construction and validation of a cuproptosis-related prognostic model for glioblastoma
por: Zhang, Bohong, et al.
Publicado: (2023)

A prognostic signature consisting of metabolism-related genes and SLC17A4 serves as a potential biomarker of immunotherapeutic prediction in prostate cancer
por: Li, He, et al.
Publicado: (2022)

Novel Immune Infiltrating Cell Signature Based on Cell Pair Algorithm Is a Prognostic Marker in Cancer
por: Zhang, Hao, et al.
Publicado: (2021)

Construction and Validation of a Novel Pyroptosis-Related Four-lncRNA Prognostic Signature Related to Gastric Cancer and Immune Infiltration
por: Wang, Zhengguang, et al.
Publicado: (2022)

Retraction: Targeting and Therapy of Glioblastoma in a Mouse Model Using Exosomes Derived From Natural Killer Cells
Publicado: (2019)

Computational identification of immune-related lncRNA signature for predicting the prognosis and immune landscape of human glioblastoma multiforme
por: Shi, Dongjie, et al.
Publicado: (2022)

Schlafen family is a prognostic biomarker and corresponds with immune infiltration in gastric cancer
por: Xu, Jiannan, et al.
Publicado: (2022)

Novel Therapy for Glioblastoma Multiforme by Restoring LRRC4 in Tumor Cells: LRRC4 Inhibits Tumor-Infitrating Regulatory T Cells by Cytokine and Programmed Cell Death 1-Containing Exosomes
por: Li, Peiyao, et al.
Publicado: (2017)

Urinary exosome microRNA signatures as a noninvasive prognostic biomarker for prostate cancer
por: Shin, Sun, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_fkf354t8t2f849636cl93b62he